Size-control of poly(epsilon-caprolactone) nanospheres by the interface effect of ethanol on the primary emulsion droplets
- PMID: 19928171
- DOI: 10.1166/jnn.2009.1270
Size-control of poly(epsilon-caprolactone) nanospheres by the interface effect of ethanol on the primary emulsion droplets
Abstract
We hypothesized that the control of the poly(epsilon-caprolactone) (PCL) nanosphere sizes could be achieved by controlling the size of the primary emulsion droplets considering a combined effect of the ethanol volume fraction in the organic phase and the stirring rate of the primary emulsion. In this way, we prepared poly(epsilon-caprolactone) (PCL) nanospheres in order to evaluate the effect of those variables on the hydrodynamic diameters of the nanoparticles by a 32 factorial design. The size distribution curves considering intensity, volume and number of particles showed monomodal distributions for all formulations. The nanoparticle diameters (z-average) decreased from 423 to 249 nm with the increase in both the ethanol volume fraction from 0.0 to 0.4 and the stirring rate from 9500 to 17500 rpm. The polydispersity indexes ranged from 0.076 to 0.176. A statistical model based on the regression coefficients calculated by the factorial design analysis was proposed in order to predict the nanoparticle diameters. Using the predictive model, the results showed high similarity between the experimental and the predicted nanosphere diameters, validating the model for loaded PCL nanospheres. The backscattering profiles of the primary emulsions prepared using different proportions of ethyl acetate and ethanol showed a reduction in the size of the droplets from 1.659 microm to 0.706 microm with the increase in the ethanol volume fraction and the stirring rate. Ethanol decreased the restoring stress of the droplets as a consequence of the reduction in the interface tension. The decrease in the nanoparticle mean size was a consequence of the droplet size reduction in the primary emulsion.
Similar articles
-
Hyaluronic acid coated poly-epsilon-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea.Exp Eye Res. 2008 Sep;87(3):162-7. doi: 10.1016/j.exer.2008.04.002. Epub 2008 Apr 12. Exp Eye Res. 2008. PMID: 18675411
-
Dynamic changes in size distribution of emulsion droplets during ethyl acetate-based microencapsulation process.AAPS PharmSciTech. 2000 Mar 23;1(1):E5. doi: 10.1208/pt010105. AAPS PharmSciTech. 2000. PMID: 14727854 Free PMC article.
-
Poly(ε-caprolactone), Eudragit® RS 100 and poly(ε-caprolactone)/Eudragit® RS 100 blend submicron particles for the sustained release of the antiretroviral efavirenz.Colloids Surf B Biointerfaces. 2013 Feb 1;102:441-9. doi: 10.1016/j.colsurfb.2012.06.038. Epub 2012 Aug 17. Colloids Surf B Biointerfaces. 2013. PMID: 23010128
-
Effects of preparation conditions on the characteristics of poly(lactide-co-glycolide) nanospheres loaded with chloro(5,10,15,20-tetraphenylporphyrinato)indium(III).J Nanosci Nanotechnol. 2011 Jun;11(6):5234-46. doi: 10.1166/jnn.2011.4136. J Nanosci Nanotechnol. 2011. PMID: 21770170
-
Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.Int J Pharm. 2009 Jun 22;375(1-2):170-6. doi: 10.1016/j.ijpharm.2009.04.007. Epub 2009 Apr 11. Int J Pharm. 2009. PMID: 19427143
Cited by
-
Nano-zinc oxide damages spatial cognition capability via over-enhanced long-term potentiation in hippocampus of Wistar rats.Int J Nanomedicine. 2011;6:1453-61. doi: 10.2147/IJN.S18507. Epub 2011 Jul 11. Int J Nanomedicine. 2011. PMID: 21796247 Free PMC article.
-
Optimization of process parameters in preparation of tocotrienol-rich red palm oil-based nanoemulsion stabilized by Tween80-Span 80 using response surface methodology.PLoS One. 2018 Aug 24;13(8):e0202771. doi: 10.1371/journal.pone.0202771. eCollection 2018. PLoS One. 2018. PMID: 30142164 Free PMC article.
-
Semi-solid topical formulations containing nimesulide-loaded nanocapsules showed in-vivo anti-inflammatory activity in chronic arthritis and fibrovascular tissue models.Inflamm Res. 2012 Apr;61(4):305-10. doi: 10.1007/s00011-011-0411-9. Epub 2011 Dec 18. Inflamm Res. 2012. PMID: 22179794
-
Development and immunobiological evaluation of nanoparticles containing an immunodominant epitope of herpes simplex virus.IET Nanobiotechnol. 2021 Aug;15(6):532-544. doi: 10.1049/nbt2.12043. Epub 2021 Mar 30. IET Nanobiotechnol. 2021. PMID: 34694744 Free PMC article.